Press Releases from Cardiovascular Disease (8 total)
Deep Research: Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class …
Researchmoz added Most up-to-date research on "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and…
Clinical Trials On Cardiovascular Disease: Frontier Pharma
Researchmoz added Most up-to-date research on "Clinical Trials On Cardiovascular Disease: Frontier Pharma" to its huge collection of research reports.
The cardiovascular disease (CVD) therapy area…
Market Overview of Cardiovascular Disease Industry 2018
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class…
Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unme …
Researchmoz added Most up-to-date research on "Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to…
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targe …
ResearchMoz added Latest Research Report titled " Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure…
Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets …
Researchmoz added Most up-to-date research on "Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and…
Global Cardiovascular Disease In-Depth Industrial and Market studies to 2022 - S …
Albany, New York, Feb 22, 2017
Description-
Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial…
Therapeutics Global Market For Cardiovascular Disease 2022 - Sanofi And Novartis …
ResearchMoz presents this most up-to-date research on "Therapeutics Global Market For Cardiovascular Disease 2022 - Sanofi And Novartis To Become Market Leaders As Praluent &…
Go To Page:
